804518-63-6
Chemical Structure
Yonkenafil
Synonym(s): Tunodafil
- CAS No.: 804518-63-6
- Formula:C24H33N5O4S
- Molecular Weight:487.61
IUPAC Name: 2-(2-ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
InChIKey: RXMDFMQMRASWOG-UHFFFAOYSA-N
SMILES: O=C1C2=C(N(CCC)C=C2C)N=C(C3=CC(S(=O)(N4CCN(CC)CC4)=O)=CC=C3OCC)N1
Biological Activity: Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. Yonkenafil may improve cognitive function by modulating neurogenesis and has a potential therapeutic effect on Alzheimer's disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Yonkenafil | 99.55% | Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. Yonkenafil may improve cognitive function by modulating neurogenesis and has a potential therapeutic effect on Alzheimer's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Yonkenafil-d8 | Yonkenafil-d8 (Tunodafil-d8) is deuterium labeled Yonkenafil. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Yonkenafil-d7 | Yonkenafil-d7 (Tunodafil-d7) is deuterium labeled Yonkenafil. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
